Search

Author/Creator Nadres, Brandon

1. A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma. (4th May 2018)

Authors:
Mooradian, Meghan J.; Reuben, Alexandre; Prieto, Peter A.; Hazar-Rethinam, Mehlika; Frederick, Dennie T.; Nadres, Brandon; Piris, Adriano; Juneja, Vikram; Cooper, Zachary A.; Sharpe, Arlene H.; Corcoran, Ryan B.; Flaherty, Keith T.; Lawrence, Donald P.; Wargo, Jennifer A.; Sullivan, Ryan J.
Journal:
Oncoimmunology
Issue:
Volume 7:Number 5(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer. (December 2021)

Authors:
McDuff, Susan G. R.; Hardiman, Karin M.; Ulintz, Peter J.; Parikh, Aparna R.; Zheng, Hui; Kim, Daniel W.; Lennerz, Jochen K.; Hazar‐Rethinam, Mehlika; Van Seventer, Emily E.; Fetter, Isobel J.; Nadres, Brandon; Eyler, Christine E.; Ryan, David P.; Weekes, Colin D.; Clark, Jeffrey W.; Cusack, Jame...
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Issue 1 (December 2017)

Authors:
Sade-Feldman, Moshe; Jiao, Yunxin; Chen, Jonathan; Rooney, Michael; Barzily-Rokni, Michal; Eliane, Jean-Pierre; Bjorgaard, Stacey; Hammond, Marc; Vitzthum, Hans; Blackmon, Shauna; Frederick, Dennie; Hazar-Rethinam, Mehlika; Nadres, Brandon; Seventer, Emily; Shukla, Sachet; Yizhak, Keren; Ray, Joh...
Journal:
Nature communications
Issue:
Volume 8:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗